These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
254 related articles for article (PubMed ID: 26048911)
1. Mucin 1 is a potential therapeutic target in cutaneous T-cell lymphoma. Jain S; Stroopinsky D; Yin L; Rosenblatt J; Alam M; Bhargava P; Clark RA; Kupper TS; Palmer K; Coll MD; Rajabi H; Pyzer A; Bar-Natan M; Luptakova K; Arnason J; Joyce R; Kufe D; Avigan D Blood; 2015 Jul; 126(3):354-62. PubMed ID: 26048911 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of the MUC1-C oncoprotein induces multiple myeloma cell death by down-regulating TIGAR expression and depleting NADPH. Yin L; Kosugi M; Kufe D Blood; 2012 Jan; 119(3):810-6. PubMed ID: 22117045 [TBL] [Abstract][Full Text] [Related]
3. Decitabine Priming Enhances Mucin 1 Inhibition Mediated Disruption of Redox Homeostasis in Cutaneous T-Cell Lymphoma. Jain S; Washington A; Leaf RK; Bhargava P; Clark RA; Kupper TS; Stroopinsky D; Pyzer A; Cole L; Nahas M; Apel A; Rosenblatt J; Arnason J; Kufe D; Avigan D Mol Cancer Ther; 2017 Oct; 16(10):2304-2314. PubMed ID: 28729399 [TBL] [Abstract][Full Text] [Related]
4. Targeting MUC1-C inhibits the AKT-S6K1-elF4A pathway regulating TIGAR translation in colorectal cancer. Ahmad R; Alam M; Hasegawa M; Uchida Y; Al-Obaid O; Kharbanda S; Kufe D Mol Cancer; 2017 Feb; 16(1):33. PubMed ID: 28153010 [TBL] [Abstract][Full Text] [Related]
5. BIN1 tumor suppressor regulates Fas/Fas ligand-mediated apoptosis through c-FLIP in cutaneous T-cell lymphoma. Esmailzadeh S; Huang Y; Su MW; Zhou Y; Jiang X Leukemia; 2015 Jun; 29(6):1402-13. PubMed ID: 25578476 [TBL] [Abstract][Full Text] [Related]
6. Evidence of an oncogenic role of aberrant TOX activation in cutaneous T-cell lymphoma. Huang Y; Su MW; Jiang X; Zhou Y Blood; 2015 Feb; 125(9):1435-43. PubMed ID: 25548321 [TBL] [Abstract][Full Text] [Related]
7. Targeting MUC1-C is synergistic with bortezomib in downregulating TIGAR and inducing ROS-mediated myeloma cell death. Yin L; Kufe T; Avigan D; Kufe D Blood; 2014 May; 123(19):2997-3006. PubMed ID: 24632713 [TBL] [Abstract][Full Text] [Related]
8. PAK1 overexpression promotes cell proliferation in cutaneous T cell lymphoma via suppression of PUMA and p21. Wang Y; Gu X; Li W; Zhang Q; Zhang C J Dermatol Sci; 2018 Apr; 90(1):60-67. PubMed ID: 29307600 [TBL] [Abstract][Full Text] [Related]
9. Histone deacetylase inhibitors inhibit metastasis by restoring a tumor suppressive microRNA-150 in advanced cutaneous T-cell lymphoma. Abe F; Kitadate A; Ikeda S; Yamashita J; Nakanishi H; Takahashi N; Asaka C; Teshima K; Miyagaki T; Sugaya M; Tagawa H Oncotarget; 2017 Jan; 8(5):7572-7585. PubMed ID: 27935859 [TBL] [Abstract][Full Text] [Related]
10. Targeting the MUC1-C oncoprotein inhibits self-renewal capacity of breast cancer cells. Alam M; Rajabi H; Ahmad R; Jin C; Kufe D Oncotarget; 2014 May; 5(9):2622-34. PubMed ID: 24770886 [TBL] [Abstract][Full Text] [Related]
11. MUC1 is a potential target for the treatment of acute myeloid leukemia stem cells. Stroopinsky D; Rosenblatt J; Ito K; Mills H; Yin L; Rajabi H; Vasir B; Kufe T; Luptakova K; Arnason J; Nardella C; Levine JD; Joyce RM; Galinsky I; Reiter Y; Stone RM; Pandolfi PP; Kufe D; Avigan D Cancer Res; 2013 Sep; 73(17):5569-79. PubMed ID: 23867470 [TBL] [Abstract][Full Text] [Related]
12. Analysis of the Effect of Gentian Violet on Apoptosis and Proliferation in Cutaneous T-Cell Lymphoma in an In Vitro Study. Wu J; Wood GS JAMA Dermatol; 2018 Oct; 154(10):1191-1198. PubMed ID: 30167641 [TBL] [Abstract][Full Text] [Related]
13. Disruption of CCL20-CCR6 interaction inhibits metastasis of advanced cutaneous T-cell lymphoma. Ikeda S; Kitadate A; Ito M; Abe F; Nara M; Watanabe A; Takahashi N; Miyagaki T; Sugaya M; Tagawa H Oncotarget; 2016 Mar; 7(12):13563-74. PubMed ID: 26789110 [TBL] [Abstract][Full Text] [Related]
14. MicroRNA-16 mediates the regulation of a senescence-apoptosis switch in cutaneous T-cell and other non-Hodgkin lymphomas. Kitadate A; Ikeda S; Teshima K; Ito M; Toyota I; Hasunuma N; Takahashi N; Miyagaki T; Sugaya M; Tagawa H Oncogene; 2016 Jul; 35(28):3692-704. PubMed ID: 26640145 [TBL] [Abstract][Full Text] [Related]
15. LW-213 induces cell apoptosis in human cutaneous T-cell lymphomas by activating PERK-eIF2α-ATF4-CHOP axis. Yu XX; Zhu MY; Wang JR; Li H; Hu P; Qing YJ; Wang XY; Wang HZ; Wang ZY; Xu JY; Guo QL; Hui H Acta Pharmacol Sin; 2021 Feb; 42(2):290-300. PubMed ID: 32747719 [TBL] [Abstract][Full Text] [Related]
16. Targeting Cutaneous T-Cell Lymphoma Cells by Ingenol Mebutate (PEP005) Correlates with PKCδ Activation, ROS Induction as Well as Downregulation of XIAP and c-FLIP. Sumarni U; Reidel U; Eberle J Cells; 2021 Apr; 10(5):. PubMed ID: 33922439 [TBL] [Abstract][Full Text] [Related]
17. Dependence on the MUC1-C oncoprotein in non-small cell lung cancer cells. Raina D; Kosugi M; Ahmad R; Panchamoorthy G; Rajabi H; Alam M; Shimamura T; Shapiro GI; Supko J; Kharbanda S; Kufe D Mol Cancer Ther; 2011 May; 10(5):806-16. PubMed ID: 21421804 [TBL] [Abstract][Full Text] [Related]
18. Bortezomib-induced apoptosis in mature T-cell lymphoma cells partially depends on upregulation of Noxa and functional repression of Mcl-1. Ri M; Iida S; Ishida T; Ito A; Yano H; Inagaki A; Ding J; Kusumoto S; Komatsu H; Utsunomiya A; Ueda R Cancer Sci; 2009 Feb; 100(2):341-8. PubMed ID: 19068089 [TBL] [Abstract][Full Text] [Related]
19. Polo-like kinase 1 (Plk1) is expressed by cutaneous T-cell lymphomas (CTCLs), and its downregulation promotes cell cycle arrest and apoptosis. Nihal M; Stutz N; Schmit T; Ahmad N; Wood GS Cell Cycle; 2011 Apr; 10(8):1303-11. PubMed ID: 21436619 [TBL] [Abstract][Full Text] [Related]
20. Induction of apoptosis by bexarotene in cutaneous T-cell lymphoma cells: relevance to mechanism of therapeutic action. Zhang C; Hazarika P; Ni X; Weidner DA; Duvic M Clin Cancer Res; 2002 May; 8(5):1234-40. PubMed ID: 12006543 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]